1. Home
  2. KLXE vs TARA Comparison

KLXE vs TARA Comparison

Compare KLXE & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$1.27

Market Cap

140.8M

Sector

Energy

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

BUY

Current Price

$2.34

Market Cap

159.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KLXE
TARA
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
159.6M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
KLXE
TARA
Price
$1.27
$2.34
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $25.71
AVG Volume (30 Days)
651.3K
★ 1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.25
EPS
N/A
★ N/A
Revenue
★ $636,600,000.00
$2,948,000.00
Revenue This Year
$4.43
N/A
Revenue Next Year
$8.47
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.24
$2.32
52 Week High
$4.50
$7.82

Technical Indicators

Market Signals
Indicator
KLXE
TARA
Relative Strength Index (RSI) 36.62 24.36
Support Level $1.24 N/A
Resistance Level $1.58 $4.13
Average True Range (ATR) 0.08 0.18
MACD 0.01 -0.02
Stochastic Oscillator 29.79 7.46

Price Performance

Historical Comparison
KLXE
TARA

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: